Search: WFRF:(Jensen Carl) > Increased retinopat...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03801naa a2200457 4500 | |
001 | oai:lup.lub.lu.se:e0706f09-ec19-4576-abf3-729d55e3ca06 | |
003 | SwePub | |
008 | 160401s2009 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/14618892 URI |
024 | 7 | a https://doi.org/10.1111/j.1755-3768.2008.01300.x2 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Fosmark, Dag S.4 aut |
245 | 1 0 | a Increased retinopathy occurrence in type 1 diabetes patients with increased serum levels of the advanced glycation endproduct hydroimidazolone |
264 | 1 | b Wiley,c 2009 |
520 | a Purpose: We aimed to investigate associations between serum levels of the advanced glycation endproduct methylglyoxal-derived hydroimidazolone (MG-H1) and retinopathy in a sample of patients with type 1 diabetes. Methods: We conducted a cross-sectional study in a Scandinavian ophthalmology outpatient clinic on 61 randomly selected patients with type 1 diabetes. Blood samples and retinal photographs were taken at the same visit. Serum levels of hydroimidazolone immunoreactivity were determined using an immunoassay, and levels of retinopathy were determined from seven standard field stereo photographs of each eye according to the ETDRS method. Results were compared between patients with and without retinopathy. Results: Hydroimidazolone quartiles were significantly associated with retinopathy (p = 0.013). The most profound increase in occurrence of retinopathy was observed from the lowest to the second-lowest hydroimidazolone quartile. Adjusted for duration of diabetes using logistic regression, a significant difference in the presence of retinopathy was found when comparing the lowest quartile with the rest (p = 0.022). Conclusions: In our patients with type 1 diabetes, serum levels of hydroimidazolone were found to be associated with retinopathy. This is in keeping with findings in a larger sample of patients with type 2 diabetes. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Oftalmologi0 (SwePub)302172 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Ophthalmology0 (SwePub)302172 hsv//eng |
653 | a MG-H1 | |
653 | a (MG) | |
653 | a methylglyoxal | |
653 | a advanced glycation endproducts (AGEs) | |
653 | a hydroimidazolone | |
653 | a retinopathy | |
653 | a type 1 diabetes | |
700 | 1 | a Berg, Jens P.4 aut |
700 | 1 | a Jensen, Aase-Brith4 aut |
700 | 1 | a Sandvik, Leiv4 aut |
700 | 1 | a Agardh, Elisabetu Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Oftalmologi (Malmö),Forskargrupper vid Lunds universitet,Department of Clinical Sciences, Malmö,Faculty of Medicine,Ophthalmology (Malmö),Lund University Research Groups4 aut0 (Swepub:lu)ofta-eag |
700 | 1 | a Agardh, Carl-Davidu Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Department of Clinical Sciences, Malmö,Faculty of Medicine4 aut0 (Swepub:lu)endo-cag |
700 | 1 | a Hanssen, Kristian F.4 aut |
710 | 2 | a Institutionen för kliniska vetenskaper, Malmöb Medicinska fakulteten4 org |
773 | 0 | t Acta Ophthalmologicad : Wileyg 87:5, s. 498-500q 87:5<498-500x 1755-3768x 1755-375X |
856 | 4 | u http://dx.doi.org/10.1111/j.1755-3768.2008.01300.xy FULLTEXT |
856 | 4 8 | u https://lup.lub.lu.se/record/1461889 |
856 | 4 8 | u https://doi.org/10.1111/j.1755-3768.2008.01300.x |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.